We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




X-Ray Powder Diffraction Technology Developed for Molecule Identification

By LabMedica International staff writers
Posted on 05 Aug 2014
A Danish researcher has developed a technique that uses X-rays for the rapid identification of substances present in an indeterminate powder. More...
The new technique has the capacity to recognize sophisticated biologic molecules such as proteins. The method therefore has enormous potential in food production and the pharmaceutical industry, where it opens up, for example, new opportunities for the quality assurance (QA) of protein-based drugs. The technique was developed by a Technical University of Denmark (DTU; Kongens Lyngby) researcher.

It is rarely sufficient to read the content information if one needs to know exactly what substances a product contains. One needs to be a very skilled chemist or to have “X-ray vision” to look directly into the molecular structure of the various substances. Christian Grundahl Frankaer, a postdoc in the DTU department of chemical engineering, is almost both, as he has developed technology that allows him to use X-rays to look deep into biologic samples.

The technique is called powder diffraction and involves subjecting a sample to an intense beam of X-rays. When the beam hits the sample, it disseminates in the same manner as light does when reflected by a disco ball. This generates a pattern that reflects the structure of the substance. Each individual substance has its own unique pattern, which makes it easily identifiable when the findings are run through a database.

Powder diffraction is currently used to identify basic substances such as salts, sugars, and minerals, but the theory behind using the same technique to characterize complicated biologic molecules such as proteins is groundbreaking. It is for this reason that the technology has huge possibilities in both food production and the pharmaceutical industry, where more and more attention is being dedicated to protein-based medicines.

“I have tested different types of infant milk formula, protein powders and detergents. By taking a small sample of powder and bombarding it with X-rays, I can determine what substances the powder contains, and in what concentrations, within 10 minutes. In addition, the analysis will typically reveal some information about how the product was made,” noted Dr. Frankaer. The method is therefore perfect for quality assurance of new products on the market.

Dr. Franaer added, “We have now demonstrated that powder diffraction can actually be used on biological substances such as proteins. The results are not as detailed as in single crystal diffraction, which makes it possible to decode the entire structure of the protein, but they do allow us to ‘lift fingerprints’ quickly and easily so that we can identify the protein and its crystal structure. This is valuable knowledge when you are working with the production of proteins.”

The technology has great potential in the framework of optimizing both quality and production processes in all production set-ups that involve solid substances. Applying the new approach will make it possible to check continuously for alterations in—or transformations of—different materials used in the production process. “The advantage of our method is that it allows you to take samples directly from a production line. You then have the results within 15 minutes and can tell precisely what crystalline material is involved. In addition, the X-ray beams we use can easily be generated using standard laboratory equipment,” stated Dr. Frankaer.

The promising findings are just beginning of the project, “What we want to do now is to test how far we can push the method. We have already established that it works on proteins, but will it also work on other complex products? And what happens if we take the samples to the synchrotron in Grenoble [France], where the X-ray beam is a million times more powerful than the one we have in our laboratory?” queried Dr. Frankaer.

Related Links:

Technical University of Denmark



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Automatic Hematology Analyzer
CF9600
New
Slide Scanner System
NanoZoomer S540MD
Thyroid Test
Anti-Thyroid EIA Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: iStock

Prehospital Blood Test Could Reduce Emergency Transfers for Chest Pain

Chest pain leads to ambulance transport to an emergency department for about 95% of patients, although only a minority have a serious cardiac condition. Troponin testing helps assess heart muscle damage,... Read more

Molecular Diagnostics

view channel
Image Credit: 123RF

Genetic Testing Program Helps Uncover Inherited Risk in Pediatric Cancer

Inherited cancer risk can affect children, adolescents and young adults, but it may not always be apparent from tumor type or family history alone. Some cancer syndromes require specialized expertise and... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Microbiology

view channel
Image: Each PhAST instrument supports random-access processing of up to four samples simultaneously, delivering a throughput of up to 12 samples per eight-hour shift. (Photo courtesy of PhAST)

FDA Clears Rapid Phenotypic Antimicrobial Susceptibility System for Positive Blood Cultures

Bloodstream infections require prompt treatment, but antimicrobial susceptibility results often lag behind a positive blood culture. Conventional testing can take another 24 to 48 hours after a culture... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.